Gene · 4734
Papers3,453
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,453
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications. | MedComm (2020) | 2025 | 40761481 | PubTator, text mining | PubMed |
| PRMT1-mediated methylation of UBE2m promoting calcium oxalate crystal-induced kidney injury by inhibiting fatty acid metabolism. | Cell Death Dis | 2025 | 40744915 | PubTator, text mining | PubMed |
| Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells. | Sci Rep | 2025 | 40731045 | PubTator, text mining | PubMed |
| STK25 Loss Augments Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Stability in Colorectal Cancer. | Adv Sci (Weinh) | 2025 | 40729594 | PubTator, text mining | PubMed |
| Intranodal palisaded myofibroblastoma shows a unique epigenetic profile-first molecular study of their epigenetic and copy number variation profile. | Virchows Arch | 2025 | 40676219 | PubTator, text mining | PubMed |
| The Functions and Mechanisms of the Cohesin Complex in Regulating the Fate Determinations of Stem Cells. | Research (Wash D C) | 2025 | 40642059 | PubTator, text mining | PubMed |
| NEDD4-Mediated Endothelial-Mesenchymal Transition Participates in Radiation-Induced Lung Injury Through the ATM Signaling Pathway. | Dose Response | 2025 | 40548124 | PubTator, text mining | PubMed |
| SMURF2 inhibition attenuates cardiac hypertrophy through blocking ubiquitination degradation of AXIN1. | Acta Pharmacol Sin | 2025 | 40542282 | PubTator, text mining | PubMed |
| Nonlytic Egress and Transmission in the Virus World. | Annu Rev Biochem | 2025 | 40540754 | PubTator, text mining | PubMed |
| Role and therapeutic potential of the NEDD4 family in breast cancer. | Front Pharmacol | 2025 | 40535763 | PubTator, text mining | PubMed |
| HECW1 Gene's Role in Gastric Cancer Prognosis and Its Suppressive Effect on Cell Progression after Knockdown. | Crit Rev Eukaryot Gene Expr | 2025 | 40530964 | PubTator, text mining | PubMed |
| Comprehensive analysis of the role of NEDD4 in pan-cancer and experimental verification of its role in KIRC progression. | Discov Oncol | 2025 | 40526226 | PubTator, text mining | PubMed |
| MASP1 as a favorable prognostic biomarker in pediatric osteosarcoma: an integrated analysis of machine learning, bioinformatics, and validation experiments. | Transl Pediatr | 2025 | 40519720 | PubTator, text mining | PubMed |
| Covalent Recruitment of NEDD4 for Targeted Protein Degradation: Rational Design of Small Molecular Degraders. | J Am Chem Soc | 2025 | 40506832 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis and m6A-Target gene signatures for diagnostic significance and immune microenvironment characterization in polycystic ovary syndrome. | Sci Rep | 2025 | 40481029 | PubTator, text mining | PubMed |
| Biochemical analysis of PD-L1 ubiquitination by CRL3SPOP, ARIH1, and NEDD4 family ubiquitin ligases. | Structure | 2025 | 40472843 | PubTator, text mining | PubMed |
| Structure-based design of potent and selective inhibitors of the HECT ligase NEDD4. | Commun Chem | 2025 | 40437006 | PubTator, text mining | PubMed |
| USP18 deubiquitinates and stabilizes SOX9 to promote the stemness and malignant progression of glioblastoma. | Cell Death Discov | 2025 | 40374599 | PubTator, text mining | PubMed |
| Experimental validation and identification of ferroptosis-associated biomarkers for diagnostic and therapeutic targeting in hearing loss. | Front Aging Neurosci | 2025 | 40353062 | PubTator, text mining | PubMed |
| Predicting Motif-Mediated Interactions Based on Viral Genomic Composition. | Int J Mol Sci | 2025 | 40332242 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4734/papers?page=6